SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees
Authors
Keywords
-
Journal
Science Immunology
Volume 6, Issue 59, Pages eabj1750
Publisher
American Association for the Advancement of Science (AAAS)
Online
2021-05-25
DOI
10.1126/sciimmunol.abj1750
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adaptive immunity to SARS-CoV-2 and COVID-19
- (2021) Alessandro Sette et al. CELL
- Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69–V70, France, August to December 2020
- (2021) Antonin Bal et al. Eurosurveillance
- Evolution of antibody immunity to SARS-CoV-2
- (2021) Christian Gaebler et al. NATURE
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)
- (2021) Jeroen J. A. van Kampen et al. Nature Communications
- Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
- (2021) Wilfredo F. Garcia-Beltran et al. CELL
- Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine induced sera
- (2021) Daming Zhou et al. CELL
- SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
- (2021) Xiaoying Shen et al. Cell Host & Microbe
- The great escape? SARS-CoV-2 variants evading neutralizing responses
- (2021) Jérémie Prévost et al. Cell Host & Microbe
- Persistence of antibodies to SARS-CoV-2 in relation to symptoms in a nationwide prospective study
- (2021) Gerco den Hartog et al. CLINICAL INFECTIOUS DISEASES
- Severe reinfection with South African SARS-CoV-2 variant 501Y.V2: A case report
- (2021) Noémie Zucman et al. CLINICAL INFECTIOUS DISEASES
- Longitudinal assessment of anti-SARS-CoV-2 immune responses for six months based on the clinical severity of COVID-19
- (2021) Ji Yun Noh et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence
- (2021) Ester C Sabino et al. LANCET
- Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein
- (2021) Houriiyah Tegally et al. NATURE
- mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
- (2021) Zijun Wang et al. NATURE
- COVID-19 vaccination: the VOICE for patients with cancer
- (2021) Astrid A. M. van der Veldt et al. NATURE MEDICINE
- Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
- (2021) Rita E. Chen et al. NATURE MEDICINE
- Neutralizing Activity of BNT162b2-Elicited Serum
- (2021) Yang Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma
- (2021) For Yue Tso et al. PLoS One
- A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker)
- (2021) Thomas Hale et al. Nature Human Behaviour
- SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses
- (2021) Benedikt Agerer et al. Science Immunology
- Prolonged evolution of the human B cell response to SARS-CoV-2 infection
- (2021) Mrunal Sakharkar et al. Science Immunology
- SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
- (2021) Markus Hoffmann et al. CELL
- Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant
- (2021) Venkata Viswanadh Edara et al. Cell Host & Microbe
- SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay
- (2021) Irene Cassaniti et al. CLINICAL MICROBIOLOGY AND INFECTION
- Longitudinal Analysis of Human Memory T-Cell Response according to the Severity of Illness up to 8 Months after SARS-CoV-2 Infection
- (2021) Chang Kyung Kang et al. JOURNAL OF INFECTIOUS DISEASES
- Correlates of protection from SARS-CoV-2 infection
- (2021) Florian Krammer LANCET
- Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection
- (2021) Salim S Abdool Karim LANCET
- Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
- (2021) Delphine Planas et al. NATURE MEDICINE
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses
- (2021) Ane Ogbe et al. Nature Communications
- SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study
- (2021) Andrew G Letizia et al. Lancet Respiratory Medicine
- CD8+ T cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating variants
- (2021) Andrew D Redd et al. Open Forum Infectious Diseases
- Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination
- (2021) Rishi R. Goel et al. Science Immunology
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- Functional exhaustion of antiviral lymphocytes in COVID-19 patients
- (2020) Meijuan Zheng et al. Cellular & Molecular Immunology
- SARS-CoV-2-specific antibody detection for sero-epidemiology: a multiplex analysis approach accounting for accurate seroprevalence
- (2020) Gerco den Hartog et al. JOURNAL OF INFECTIOUS DISEASES
- The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study
- (2020) Camille Maringe et al. LANCET ONCOLOGY
- SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
- (2020) Julian Braun et al. NATURE
- A single-cell atlas of the peripheral immune response in patients with severe COVID-19
- (2020) Aaron J. Wilk et al. NATURE MEDICINE
- Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
- (2020) Philip J. M. Brouwer et al. SCIENCE
- Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
- (2020) Jose Mateus et al. SCIENCE
- An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment
- (2020) Corine H. GeurtsvanKessel et al. Nature Communications
- Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome
- (2020) Daniela Weiskopf et al. Science Immunology
- Genomic evidence for reinfection with SARS-CoV-2: a case study
- (2020) Richard L Tillett et al. LANCET INFECTIOUS DISEASES
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
- (2020) Ugur Sahin et al. NATURE
- High levels of SARS-CoV-2–specific T cells with restricted functionality in severe courses of COVID-19
- (2020) David Schub et al. JCI Insight
- Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019
- (2020) Jee-Soo Lee et al. CLINICAL INFECTIOUS DISEASES
- The Importance and Challenges of Identifying SARS-CoV-2 Reinfections
- (2020) Ahmed Babiker et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
- (2020) Alicia T. Widge et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity
- (2020) Mads Delbo Larsen et al. SCIENCE
- Primary Human Influenza B Virus Infection Induces Cross-Lineage Hemagglutinin Stalk–Specific Antibodies Mediating Antibody-Dependent Cellular Cytoxicity
- (2017) Rory D de Vries et al. JOURNAL OF INFECTIOUS DISEASES
- Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection
- (2017) Rory D. de Vries et al. VACCINE
- Pre-fusion structure of a human coronavirus spike protein
- (2016) Robert N. Kirchdoerfer et al. NATURE
- Age-Associated Cross-reactive Antibody-Dependent Cellular Cytotoxicity Toward 2009 Pandemic Influenza A Virus Subtype H1N1
- (2013) Sinthujan Jegaskanda et al. JOURNAL OF INFECTIOUS DISEASES
- Specificity and affinity of human Fc receptors and their polymorphic variants for human IgG subclasses
- (2008) P. Bruhns et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now